| DSDs | Differences of sexual development |
| EDCs | Endocrine disrupting chemicals |
| TDS | Testicular dysgenesis syndrome |
| POI | Premature ovarian insufficiency |
| PCOS | Polycystic ovary syndrome |
| ER | Oestrogen receptor |
| NT2/D1 | NTERA-2 clone D1 |
| SOX9 | Sex-determining region Y box transcription factor 9 |
| SRY | Sex-determining region Y |
| AMH | Anti-Mullerian hormone |
| FGF9 | Fibroblast growth factor |
| PTGDS | Prostaglandin D synthase |
| SF1 | Steroidogenic factor 1 |
| FOXL2 | Forkhead box L2 |
| RSPO1 | R-spondin 1 |
| WNT4 | Wnt family member 4 |
| FST | Follistatin |
| BMP2 | Bone morphogenetic protein 2 |
| ERK1/2 | Extracellular regulated kinases 1/2 |
| MAP3K | Mitogen-activated protein kinase kinase kinase |
| GATA4 | GATA binding protein 4 |
| RHOA | Ras homolog family member A |
| ROCK | Rho-associated coiled coil containing protein kinase |
| RAC1 | Rac family small GTPase 1 |
| GSK3β | Glycogen synthase kinase 3β |
| FRAT1 | FRAT regulator of Wnt signalling pathway 1 |
| GADD45γ | Growth arrest and DNA damage-inducible protein γ |
| PKA | Protein kinase A |
| AKT | AKT serine/threonine kinase |
| PAK1 | p21 (RAC1) activated kinase 1 |